KalVista Pharmaceuticals, Inc.
KALV
$20.48
$0.924.70%
NASDAQ
| 12/31/2025 | 09/30/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 18.57% | -- | 9.87% | 4.86% | 234.99% |
| Total Receivables | 20.21% | -- | -47.14% | 39.28% | -60.30% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 9.44% | -- | 56.50% | 34.27% | -1.68% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 19.74% | 113.59% | 7.44% | 7.09% | 156.82% |
|
|
|||||
| Total Current Assets | 19.74% | 113.59% | 7.44% | 7.09% | 156.82% |
| Net Property, Plant & Equipment | 77.44% | -- | -9.13% | -17.66% | -23.46% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 70.80% | -- | 292.89% | 173.02% | 249.37% |
| Total Assets | 21.52% | 111.36% | 7.65% | 6.53% | 142.17% |
|
|
|||||
| Total Accounts Payable | 41.19% | -- | -45.62% | -46.38% | 88.84% |
| Total Accrued Expenses | 47.75% | -- | 83.21% | 118.21% | 23.42% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 951.94% | -- | 67.88% | 51.84% | 21.65% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 4,566.40% | -- |
| Total Other Current Liabilities | -- | -- | -- | 4,566.40% | -- |
| Total Current Liabilities | 123.91% | 103.34% | 71.23% | 98.04% | 33.91% |
|
|
|||||
| Total Current Liabilities | 123.91% | 103.34% | 71.23% | 98.04% | 33.91% |
| Long-Term Debt | 155.95% | -- | -- | 1,660.30% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 147.28% | -- | -19.43% | -28.01% | -30.67% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 158.34% | 1,103.22% | 537.67% | 439.10% | 415.53% |
|
|
|||||
| Common Stock & APIC | 2.52% | -- | 10.88% | 10.88% | 44.75% |
| Retained Earnings | -26.92% | -33.79% | -39.81% | -39.05% | -41.37% |
| Treasury Stock & Other | -222.87% | -- | -122.62% | -49.48% | 32.97% |
| Total Common Equity | -101.87% | -87.31% | -76.39% | -53.82% | 63.83% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -101.87% | -87.31% | -76.39% | -53.82% | 63.83% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -101.87% | -- | -76.39% | -53.82% | 63.83% |
|
|
|||||